Paul S Charifson Selected Research

Community-Acquired Infections

9/2008	Novel dual-targeting benzimidazole urea inhibitors of DNA gyrase and topoisomerase IV possessing potent antibacterial activity: intelligent design and evolution through the judicious use of structure-guided design and structure-activity relationships.
4/2006	In vitro characterization of the antibacterial spectrum of novel bacterial type II topoisomerase inhibitors of the aminobenzimidazole class.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Paul S Charifson Research Topics

Disease

6	Human Influenza (Influenza) 02/2017 - 08/2014
3	Infections 10/2015 - 09/2008
2	Adrenoleukodystrophy (Adrenoleukodystrophy, X-Linked) 12/2021 - 12/2021
2	Community-Acquired Infections 09/2008 - 04/2006
1	Bacterial Infections (Bacterial Infection) 11/2014

Drug/Important Bio-Agent (IBA)

5	Antiviral Agents (Antivirals)IBA 02/2017 - 08/2014
3	pimodivirIBA 02/2017 - 03/2015
2	Fatty Acids (Saturated Fatty Acids)IBA 12/2021 - 12/2021
2	EnzymesIBA 12/2021 - 09/2008
2	Neuraminidase (Sialidase)IBA 10/2015 - 03/2015
2	Pharmaceutical PreparationsIBA 05/2015 - 03/2015
1	Adenosine Triphosphate (ATP)IBA 12/2021
1	Proteins (Proteins, Gene)FDA Link 12/2021
1	Amino Acids FDA Link 02/2017
1	7-azaindole dimerIBA 02/2017
1	VX (EDIM)IBA 05/2015
1	Carboxylic AcidsIBA 05/2015
1	Phosphotransferases (Kinase)IBA 05/2015
1	Oseltamivir (Tamiflu)FDA Link 03/2015
1	Urea (Carbamide)FDA LinkGeneric 11/2014
1	DNA Topoisomerase IV (Topoisomerase IV)IBA 11/2014
1	benzimidazoleIBA 09/2008
1	DNA GyraseIBA 04/2006

Therapy/Procedure

1	Therapeutics 03/2015
1	Intravenous Administration 09/2008